Natera, Inc. (NTRA)
325.45
-2.22
(-0.68%)
USD |
NASDAQ |
Sep 04, 10:31
Natera Cash and Short Term Investments (Quarterly) : 1.092B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.092B |
| March 31, 2026 | 1.088B |
| December 31, 2025 | 1.076B |
| September 30, 2025 | 1.042B |
| June 30, 2025 | 1.016B |
| March 31, 2025 | 991.60M |
| December 31, 2024 | 968.28M |
| September 30, 2024 | 922.33M |
| June 30, 2024 | 887.10M |
| March 31, 2024 | 882.94M |
| December 31, 2023 | 878.98M |
| September 30, 2023 | 936.56M |
| June 30, 2023 | 735.94M |
| March 31, 2023 | 812.01M |
| December 31, 2022 | 898.39M |
| September 30, 2022 | 521.24M |
| June 30, 2022 | 638.74M |
| March 31, 2022 | 752.19M |
| December 31, 2021 | 914.51M |
| September 30, 2021 | 1.024B |
| June 30, 2021 | 580.47M |
| March 31, 2021 | 653.74M |
| December 31, 2020 | 737.46M |
| Date | Value |
|---|---|
| September 30, 2020 | 809.73M |
| June 30, 2020 | 571.23M |
| March 31, 2020 | 405.88M |
| December 31, 2019 | 441.05M |
| September 30, 2019 | 238.36M |
| June 30, 2019 | 238.04M |
| March 31, 2019 | 128.48M |
| December 31, 2018 | 158.46M |
| September 30, 2018 | 169.65M |
| June 30, 2018 | 88.82M |
| March 31, 2018 | 119.37M |
| December 31, 2017 | 118.93M |
| September 30, 2017 | 146.27M |
| June 30, 2017 | 102.89M |
| March 31, 2017 | 116.55M |
| December 31, 2016 | 147.21M |
| September 30, 2016 | 184.23M |
| June 30, 2016 | 216.48M |
| March 31, 2016 | 231.90M |
| December 31, 2015 | 231.43M |
| September 30, 2015 | 222.77M |
| June 30, 2015 | 62.39M |
| March 31, 2015 | 80.54M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Guardant Health, Inc. | 1.053B |
| CareDx, Inc. | 373.64M |
| Myriad Genetics, Inc. | 115.20M |
| BioRestorative Therapies, Inc. | 3.592M |
| Exagen, Inc. | 24.59M |